Search results
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 3 hours agoInsmed’s stocks more than doubled after the company announced its lead-pipeline candidate...
Insmed shares double as lung drug data convince Wall Street
BioPharma Dive via Yahoo Finance· 1 day agoAfter reporting positive clinical trial results for its drug brensocatib, Insmed plans to later this...
Imaginary placebo intake study investigates neural response for regulating disgust
Medical Xpress· 5 days agoA study has compared the effects of a placebo pill and an imaginary pill in reducing visually...
IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies
Clinical Trials Arena via Yahoo Finance· 2 hours agoThe placebo-controlled, parallel, multi-site, double-blind, randomised trial will assess IGC-AD1 to...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
WTNH-TV New Haven· 4 days agoPatients treated with Fabhalta in addition to supportive care achieved a 35.1% (p=0.0014) reduction...
Otsuka and Lundbeck report data from three PTSD treatment trials
Clinical Trials Arena via Yahoo Finance· 4 hours agoThe change in the CAPS-5 total score from week one to week ten for the brexpiprazole and sertraline...
Triamcinolone Offers Relief in Thyroid Eye Disease
Medscape· 8 hours agoPercutaneous injection of triamcinolone improved margin reflex distance 1 and upper eyelid retraction in patients with thyroid eye disease.
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
WROC Rochester· 4 days agoIn the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS)...
Insmed shares skyrocket on positive trial results for lung drug By Proactive Investors
Investing.com· 20 hours agoThe company said patients in the study with non-cystic fibrosis bronchiectasis who were dosed with...
Insmed shares target raised by H.C. Wainwright on positive trial data By Investing.com
Investing.com· 2 hours agoThe ASPEN trial results showed a reduction in annualized rates of pulmonary exacerbations (PEs) for...